⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
PegIntron Market Outlook 2026-2030 & 2035: Epidemiology, Pipeline, and Competition Insights Worldwide
globenewswire.com
MRK
PegIntron or Rebetol Combo Pack Market Report 2026: Rising Chronic Hepatitis C and Leukemia Cases Drives Industry Growth
globenewswire.com
MRK
Your Next Dental Appointment May Save Your Life
globenewswire.com
MRK
CORRECTION FROM SOURCE: CIO 100 Awards & Conference Announces 2026 CIO 100 Honorees, Recognizing Enterprise-Scale Technology Leadership
accessnewswire.com
HPE
IBM
AVNT
BAC
BSM
CTSH
DELL
DOX
DG
DD
ECL
FDX
FICO
INTC
JNJ
MA
OII
PEP
QCOM
RS
S
TMO
TRV
UNM
UPS
VZ
WCC
ABBV
ACAD
AES
ALB
ALLY
AMAT
AZN
T
AVPT
CBRE
CI
COST
DE
EL
GE
GILD
JLL
JPM
KHC
LMT
MS
NWSA
PENN
PFE
REGN
ROK
SAN
SM
SIRI
TMUS
TRIP
WEN
CVS
AMZN
GOOGL
MSFT
ORCL
CRM
ADBE
NFLX
NVDA
AMD
CSCO
HPQ
ACN
ADP
AMGN
BA
CAT
CMCSA
COP
DIS
DOW
EOG
HON
KO
LIN
LRCX
MDT
META
MRK
MU
NEE
RTX
SBUX
SMCI
SNPS
SO
SPG
TCOM
TGT
TXN
UNH
VRTX
WFC
XOM
ZTS
Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection
prnewswire.com
MRK
$4.26 Billion Brain Tumor Drugs Market 2026: Trends and Growth Outlook to 2030 & 2035
globenewswire.com
SYK
AMGN
PFE
MRK
Proxygen Appoints Chiara Conti, Ph.D. as Chief Scientific Officer to Drive Clinical Translation and Expand Induced Proximity Platform Beyond Degradation
globenewswire.com
MRK
Oncologists Industry to Grow by $4 Billion Globally During 2026-2030: Assessment of the Lucrative Trends and Opportunities by Region
globenewswire.com
PFE
MRK
ABBV
GEHC
Ivonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026
prnewswire.com
MRK
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
businesswire.com
MRK